Nothing Special   »   [go: up one dir, main page]

JP2000290265A - Preparation of oxazolidine-2-ones - Google Patents

Preparation of oxazolidine-2-ones

Info

Publication number
JP2000290265A
JP2000290265A JP9752999A JP9752999A JP2000290265A JP 2000290265 A JP2000290265 A JP 2000290265A JP 9752999 A JP9752999 A JP 9752999A JP 9752999 A JP9752999 A JP 9752999A JP 2000290265 A JP2000290265 A JP 2000290265A
Authority
JP
Japan
Prior art keywords
group
substituted
ones
following formula
dioxolan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9752999A
Other languages
Japanese (ja)
Other versions
JP3740886B2 (en
Inventor
Yoshiro Furukawa
喜朗 古川
Keisuke Yaegashi
啓介 八重樫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Soda Co Ltd
Original Assignee
Daiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiso Co Ltd filed Critical Daiso Co Ltd
Priority to JP9752999A priority Critical patent/JP3740886B2/en
Publication of JP2000290265A publication Critical patent/JP2000290265A/en
Application granted granted Critical
Publication of JP3740886B2 publication Critical patent/JP3740886B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain oxazolidine-2-ones in an excellent yield by reacting dioxolane-2-ones with isocyanates in the presence of a fluoride without reducing optical purity in the case of using an optical active starting material. SOLUTION: The oxazolidine-2-ones of formula III are obtained by reacting (A) the 1,3-dioxolane-2-ones of formula I (R1 to R4 are each H, an alkyl, an alkoxy, an aralkyl, an aryl or the like), (B) the isocyanates of formula II (R5 is H, an alkyl, an aralkyl, a halogenosulfonyl, a trialkylsillyl or the like) in the presence of (C) the fluorine salt [preferably, an alkali (alkaline earth) metal salt, especially CsF or KF]. This reaction is preferably carried out by using N,N'-dimethylformamide or dimethylsulfoxide as the reaction solvent The component B is preferably used in amount of 0.8-1.5 equivalent to the component A.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は医薬、農薬などの合
成中間体として有用なオキサゾリジン−2−オン類の新
規製造方法に関する。
[0001] The present invention relates to a novel method for producing oxazolidine-2-ones useful as synthetic intermediates for pharmaceuticals, agricultural chemicals and the like.

【0002】[0002]

【従来の技術】オキサゾリジン−2−オン類は、古くか
ら知られている産業上有用な化合物である。とりわけ医
薬分野における有用性は高く、この化合物を合成中間体
とした医薬品が近年数多く開発されている。それ故、こ
の化合物の製造方法に関する報告は数多く多種多様であ
るが、その中で効率的な製造方法と言えるものの一つと
して1,3−ジオキソラン−2−オン類から環変換によ
りオキサゾリジン−2−オン類へ導く方法が挙げられ
る。この方法は、原料である1,3−ジオキソラン−2
−オン類の前駆体が比較的入手容易な1,2−ジオール
類であり、その入手容易な1,2−ジオール類から少な
い工程数でオキサゾリジン−2−オン類に変換できる点
で効率的な製造方法と言える。殊に、1,3−ジオキソ
ラン−2−オン類に塩化リチウム存在下、エチレンカー
ボネートあるいはプロピレンカーボネートとイソシアネ
ート誘導体を反応させる方法(Chem. Ber., 93, 1975
(1960))が知られている。
2. Description of the Related Art Oxazolidin-2-ones are industrially useful compounds which have been known for a long time. In particular, its usefulness in the pharmaceutical field is high, and many pharmaceuticals using this compound as a synthetic intermediate have been developed in recent years. Therefore, there are many and various reports on the production method of this compound. Among them, one of the efficient production methods is oxazolidin-2-one by ring conversion from 1,3-dioxolan-2-ones. There is a method of leading to ons. This method uses 1,3-dioxolan-2 as a raw material.
-Ones are relatively easily available 1,2-diols, and are efficient in that they can be converted to oxazolidin-2-ones from the easily available 1,2-diols in a small number of steps. It can be said to be a manufacturing method. Particularly, a method of reacting 1,3-dioxolan-2-ones with an isocyanate derivative with ethylene carbonate or propylene carbonate in the presence of lithium chloride (Chem. Ber., 93 , 1975)
(1960)) is known.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、この方
法は、低活性の塩化リチウムを用いる関係上苛酷な条件
下反応させる必要がある。そして、原料として光学活性
な1,3−ジオキソラン−2−オン類を用いると得られ
る目的物の光学純度が有意に低下する。
However, this method requires the reaction to be carried out under severe conditions because of the low activity of lithium chloride. When the optically active 1,3-dioxolan-2-ones are used as a raw material, the optical purity of the obtained target product is significantly reduced.

【0004】[0004]

【課題を解決するための手段】本発明者らは、下記式
(1)で表される1,3−ジオキソラン−2−オン類と
下記式(2)で表されるイソシアネート類とをフッ素塩
存在下反応させることにより収率よく、そして光学活性
体を用いた場合には、光学純度を損なうことなく下記式
(3)で表されるオキサゾリジン−2−オン類を製造で
きることを見出し、本発明を完成するに至った。すなわ
ち、本発明は下記式(1)
Means for Solving the Problems The inventors of the present invention have prepared a fluorine salt of a 1,3-dioxolan-2-one represented by the following formula (1) and an isocyanate represented by the following formula (2). The present invention has been found that the oxazolidin-2-ones represented by the following formula (3) can be produced without impairing optical purity by using the optically active substance in a good yield by reacting in the presence of the compound. Was completed. That is, the present invention provides the following formula (1)

【化7】 (式中R1、R2、R3およびR4は、水素原子、直鎖, 分
岐もしくは環状のアルキル基、アルコキシ基, 置換アミ
ノ基あるいはアルキルチオ基を有する直鎖もしくは分岐
のアルキル基、置換もしくは無置換のアラルキル基、ま
たは置換もしくは無置換のアリール基を意味する。)で
表される1,3−ジオキソラン−2−オン類あるいはそ
の光学活性体と下記式(2)
Embedded image (Wherein R 1 , R 2 , R 3 and R 4 are a hydrogen atom, a linear or branched alkyl group having a linear or branched or cyclic alkyl group, an alkoxy group, a substituted amino group or an alkylthio group, a substituted or 1,3-dioxolan-2-ones represented by an unsubstituted aralkyl group or a substituted or unsubstituted aryl group) or an optically active substance thereof, and the following formula (2)

【化8】 (式中R5は、水素原子、直鎖,分岐もしくは環状のアル
キル基、置換もしくは無置換のアラルキル基、ハロゲノ
スルホニル基、トリアルキルシリル基、置換もしくは無
置換のアリールスルホニル基、または置換もしくは無置
換の芳香族基を意味する。)で表されるイソシアネート
類とを、フッ素塩存在下反応させることを特徴とする下
記式(3)
Embedded image (Wherein R 5 represents a hydrogen atom, a linear, branched or cyclic alkyl group, a substituted or unsubstituted aralkyl group, a halogenosulfonyl group, a trialkylsilyl group, a substituted or unsubstituted arylsulfonyl group, or a substituted or unsubstituted Is substituted with an isocyanate represented by the following formula (3):

【化9】 (式中R1、R2、R3、R4およびR5は、前掲と同じ基
を意味する。)で表されるオキサゾリジン−2−オン類
あるいはその光学活性体の製造方法に関する。
Embedded image (Wherein R 1 , R 2 , R 3 , R 4 and R 5 mean the same groups as described above) or a process for producing an optically active form thereof.

【0005】式(1)において、R1、R2、R3および
4で表される基の具体例としては、水素原子、メチル,
エチル,イソプロピル,シクロプロピル,シクロヘキシル
基などの直鎖,分岐もしくは環状のアルキル基、メトキ
シメチル,メトキシエチル,ベンジルオキシメチル基など
のアルコキシアルキル基、ジメチルアミノメチル,ピペ
リジノエチル,モルホリノエチル,N−ベンジルオキシカ
ルボニルピペラジノメチル,N−メチルピペラジノメチ
ル,N−エトキシカルボニルメチルピペラジノメチル基
などの置換アミノアルキル基、メチルチオメチル,メチ
ルチオエチル基などのアルキルチオアルキル基、ベンジ
ル,メチルベンジル,メトキシベンジル基などの置換もし
くは無置換のアラルキル基、フェニル,トリル,メトキシ
フェニル基などの置換もしくは無置換のアリール基が挙
げられる。そのうち好ましい基は、水素原子、C1〜C4
の低級アルキル基、メトキシメチル基、ベンジルオキシ
メチル基、ベンジル基である。
In the formula (1), specific examples of the groups represented by R 1 , R 2 , R 3 and R 4 include a hydrogen atom, methyl,
Linear, branched or cyclic alkyl groups such as ethyl, isopropyl, cyclopropyl, cyclohexyl groups, alkoxyalkyl groups such as methoxymethyl, methoxyethyl, benzyloxymethyl groups, dimethylaminomethyl, piperidinoethyl, morpholinoethyl, N-benzyloxy Substituted aminoalkyl groups such as carbonylpiperazinomethyl, N-methylpiperazinomethyl, N-ethoxycarbonylmethylpiperazinomethyl group, alkylthioalkyl groups such as methylthiomethyl and methylthioethyl groups, benzyl, methylbenzyl, methoxybenzyl And substituted or unsubstituted aryl groups such as phenyl, tolyl, and methoxyphenyl groups. Among them, preferred groups are a hydrogen atom, C 1 -C 4
Are a lower alkyl group, a methoxymethyl group, a benzyloxymethyl group, and a benzyl group.

【0006】式(2)において、R5で表される基の具
体例としては、水素原子、メチル,エチル,イソプロピ
ル,シクロプロピル基などの直鎖,分岐もしくは環状のア
ルキル基、ベンジル,メチルベンジル,メトキシベンジル
基などの置換もしくは無置換のアラルキル基、クロロス
ルホニル基などのハロゲノスルホニル基、トリメチルシ
リル基などのトリアルキルシリル基、ベンゼンスルホニ
ル,o−トルエンスルホニル,p−トルエンスルホニル,
4−クロロベンゼンスルホニル基などの置換もしくは無
置換のアリールスルホニル基、フェニル,シアノフェニ
ル,トリル,メトキシフェニル基などの置換もしくは無置
換のアリール基、ナフタレン,アントラセンのような多
環式芳香族基、またフリル,チエニル,ピリジル,ピリミ
ジル,キノリル,ベンゾフリル,ベンゾチエニルのような
芳香族複素環基が挙げられる。そのうち好ましい基は、
水素原子、C1〜C4の低級アルキル基、ベンジル基、フ
ェニル基、シアノフェニル基、ナフチル基、チエニル基
である。
In the formula (2), specific examples of the group represented by R 5 include a hydrogen atom, a linear, branched or cyclic alkyl group such as methyl, ethyl, isopropyl and cyclopropyl, benzyl and methylbenzyl. , A substituted or unsubstituted aralkyl group such as a methoxybenzyl group, a halogenosulfonyl group such as a chlorosulfonyl group, a trialkylsilyl group such as a trimethylsilyl group, benzenesulfonyl, o-toluenesulfonyl, p-toluenesulfonyl,
Substituted or unsubstituted arylsulfonyl group such as 4-chlorobenzenesulfonyl group, substituted or unsubstituted aryl group such as phenyl, cyanophenyl, tolyl, methoxyphenyl group, naphthalene, polycyclic aromatic group such as anthracene, Examples include aromatic heterocyclic groups such as furyl, thienyl, pyridyl, pyrimidyl, quinolyl, benzofuryl, and benzothienyl. Among them, preferred groups are
Hydrogen atom, a lower alkyl group of C 1 -C 4, benzyl group, phenyl group, cyanophenyl group, a naphthyl group, a thienyl group.

【0007】本反応に用いられるイソシアネート類
(2)の量は1,3−ジオキソラン−2−オン類(1)
に対して0.5当量以上であり、好ましくは0.8〜1.
5当量、さらに好ましくは0.9〜1.1当量である。
The amount of isocyanates (2) used in this reaction is 1,3-dioxolan-2-ones (1)
0.5 equivalent or more, preferably 0.8 to 1.
It is 5 equivalents, more preferably 0.9 to 1.1 equivalents.

【0008】本反応に用いられるフッ素塩としては、フ
ッ素の四級アンモニウム塩、フッ素のアルカリ金属塩ま
たはフッ素のアルカリ土類金属塩が好ましく、特に好ま
しくはフッ素のアルカリ金属塩またはフッ素のアルカリ
土類金属塩である。なお、それらを単独で用いても2種
類以上の混合物で用いても、さらには適当な担体に担持
したものを用いても同様に反応を行うことができる。フ
ッ素の四級アンモニウム塩としては、テトラメチルアン
モニウムフルオライド、テトラエチルアンモニウムフル
オライド、テトラブチルアンモニウムフルオライド、テ
トラオクチルアンモニウムフルオライド、ベンジルトリ
メチルアンモニウムフルオライドなどが挙げられる。フ
ッ素のアルカリ金属塩としてはフッ化ナトリウム、フッ
化カリウム、フッ化セシウムが挙げられ、フッ素のアル
カリ土類金属塩としてはフッ化マグネシウム、フッ化カ
ルシウムが挙げられる。また、担体として用いることの
できるものとしては、ゼオライト、アルミナ、シリカゲ
ル、モレキュラーシーブスおよびそれらを修飾したもの
などが挙げられる。
The fluorine salt used in this reaction is preferably a quaternary ammonium salt of fluorine, an alkali metal salt of fluorine or an alkaline earth metal salt of fluorine, particularly preferably an alkali metal salt of fluorine or alkaline earth metal of fluorine. It is a metal salt. In addition, the reaction can be carried out in the same manner by using them alone or as a mixture of two or more kinds, or by using those supported on a suitable carrier. Examples of the quaternary ammonium salt of fluorine include tetramethylammonium fluoride, tetraethylammonium fluoride, tetrabutylammonium fluoride, tetraoctylammonium fluoride, and benzyltrimethylammonium fluoride. Alkali metal salts of fluorine include sodium fluoride, potassium fluoride and cesium fluoride, and alkaline earth metal salts of fluorine include magnesium fluoride and calcium fluoride. Examples of the carrier that can be used include zeolite, alumina, silica gel, molecular sieves, and modified products thereof.

【0009】フッ素塩の量は、反応基質の1,3−ジオ
キソラン−2−オン類(1)に対して0.001〜10
当量が好ましく、特に好ましくは0.01〜1当量であ
る。0.001当量以下では反応の進行が非常に遅く、
10当量を越えて使用してもよいが経済的でない。ま
た、溶媒によっては過剰のフッ素塩が不溶となるため撹
拌が困難となる。
The amount of the fluorine salt is 0.001 to 10 based on the reaction substrate 1,3-dioxolan-2-ones (1).
The equivalent is preferable, and particularly preferably 0.01 to 1 equivalent. If the amount is less than 0.001 equivalent, the progress of the reaction is very slow.
Although it may be used in excess of 10 equivalents, it is not economical. Further, depending on the solvent, excess fluorine salt becomes insoluble, so that stirring becomes difficult.

【0010】本反応を行う際に用いられる溶媒として
は、N,N−ジメチルホルムアミド、ジメチルスルホキ
シドなどの非プロトン性極性溶媒、ジグライム、トリグ
ライム、1,4−ジオキサン、1,2−ジメトキシエタ
ン、t−ブチルメチルエーテル等のエーテル系溶媒、ク
ロロホルム、ジクロロエタン等の塩素系溶媒ならびにこ
れらの混合溶媒等が挙げられるが、好ましい溶媒は、
N,N−ジメチルホルムアミド、ジメチルスルホキシド
である。
Solvents used in this reaction include aprotic polar solvents such as N, N-dimethylformamide and dimethylsulfoxide, diglyme, triglyme, 1,4-dioxane, 1,2-dimethoxyethane, t Ether solvents such as -butyl methyl ether, chloroform, chlorine solvents such as dichloroethane and the like, and a mixed solvent thereof, and the like.
N, N-dimethylformamide and dimethylsulfoxide.

【0011】反応温度は、加熱下50℃〜溶媒の還流温
度までで、好ましくは100℃〜150℃である。反応
終了後は、フッ素の金属塩等の不溶物を濾去、過剰の溶
媒を減圧下に留去し、残渣を蒸留、再結晶、シリカゲル
カラムクロマトグラフィー等の精製処理をすることによ
り、目的とするオキサゾリジン−2−オン類(3)ある
いはその光学活性体が得られる。
The reaction temperature ranges from 50 ° C. to the reflux temperature of the solvent under heating, preferably from 100 ° C. to 150 ° C. After completion of the reaction, insolubles such as metal salts of fluorine are removed by filtration, excess solvent is distilled off under reduced pressure, and the residue is subjected to purification treatment such as distillation, recrystallization, silica gel column chromatography, etc. Oxazolidin-2-ones (3) or an optically active form thereof are obtained.

【0012】[0012]

【実施例】以下に実施例により本発明を具体的に述べ
る。しかし本発明はこれら実施例に限定されるものでは
ない。
The present invention will be specifically described below with reference to examples. However, the present invention is not limited to these examples.

【0013】実施例1 (R)−3−フェニル−5−メトキシメチルオキサゾリ
ジン−2−オンの製造:フェニルイソシアネート18.
0g(0.151 mol)をジメチルスルホキシド1
00mLに溶解し、フッ化セシウム2.29g(15.
1 mmol)、(S)−4−メトキシメチル−1,3
−ジオキソラン−2−オン20.0g(0.151 m
ol、光学純度98%ee)を順次加え、アルゴン気流
下140℃で9時間撹拌する。不溶物を瀘去し、瀘液を
減圧下濃縮した後、残渣をシリカゲルカラムクロマトグ
ラフィーにより精製して標題の(R)−3−フェニル−
5−メトキシメチルオキサゾリジン−2−オン29.9
g(収率95.4%、光学純度98%ee)を得た。
Example 1 Preparation of (R) -3-phenyl-5-methoxymethyloxazolidin-2-one: phenyl isocyanate
0 g (0.151 mol) of dimethyl sulfoxide 1
Dissolved in 100 mL, and 2.29 g of cesium fluoride (15.
1 mmol), (S) -4-methoxymethyl-1,3
-Dioxolan-2-one 20.0 g (0.151 m
ol and an optical purity of 98% ee) are sequentially added, and the mixture is stirred at 140 ° C. for 9 hours under an argon stream. After filtering off the insolubles and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R) -3-phenyl-
5-methoxymethyloxazolidin-2-one 29.9
g (yield 95.4%, optical purity 98% ee) was obtained.

【0014】実施例2 (R)−3−フェニル−5−メトキシメチルオキサゾリ
ジン−2−オンの製造:フェニルイソシアネート18.
0g(0.151 mol)をN,N−ジメチルホルム
アミド100mLに溶解し、フッ化セシウム2.29g
(15.1 mmol)、(S)−4−メトキシメチル
−1,3−ジオキソラン−2−オン20.0g(0.1
51 mol、光学純度98%ee)を順次加え、アル
ゴン気流下140℃で8時間撹拌する。不溶物を瀘去
し、瀘液を減圧下濃縮した後、残渣をシリカゲルカラム
クロマトグラフィーにより精製して標題の(R)−3−
フェニル−5−メトキシメチルオキサゾリジン−2−オ
ン28.7g(収率91.7%、光学純度98%ee)
を得た。
Example 2 Preparation of (R) -3-phenyl-5-methoxymethyloxazolidin-2-one: phenyl isocyanate
0 g (0.151 mol) was dissolved in 100 mL of N, N-dimethylformamide, and 2.29 g of cesium fluoride was dissolved.
(15.1 mmol), 20.0 g of (S) -4-methoxymethyl-1,3-dioxolan-2-one (0.1
51 mol and an optical purity of 98% ee) are sequentially added, and the mixture is stirred at 140 ° C. for 8 hours under an argon stream. After filtering off the insoluble matter and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R) -3-
28.7 g of phenyl-5-methoxymethyloxazolidin-2-one (91.7% yield, 98% ee optical purity)
I got

【0015】実施例3 (S)−3−フェニル−5−メチルオキサゾリジン−2
−オンの製造:フェニルイソシアネート23.3g
(0.196 mol)をジメチルスルホキシド100
mLに溶解し、フッ化セシウム2.98g(19.6
mmol)、(S)−4−メチル−1,3−ジオキソラ
ン−2−オン20.0g(0.196mol、光学純度
99%ee)を順次加え、アルゴン気流下140℃で8
時間撹拌する。不溶物を瀘去し、瀘液を減圧下濃縮した
後、残渣をシリカゲルカラムクロマトグラフィーにより
精製して標題の(S)−3−フェニル−5−メチルオキ
サゾリジン−2−オン32.0g(収率92.1%、光
学純度99%ee)を得た。
Example 3 (S) -3-phenyl-5-methyloxazolidine-2
Preparation of -one: 23.3 g of phenyl isocyanate
(0.196 mol) in dimethyl sulfoxide 100
and dissolved in cesium fluoride 2.98 g (19.6).
mmol) and 20.0 g (0.196 mol, optical purity 99% ee) of (S) -4-methyl-1,3-dioxolan-2-one were added in succession, and 8
Stir for hours. After filtering off the insoluble matter and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give 32.0 g of the title (S) -3-phenyl-5-methyloxazolidine-2-one (yield). 92.1% and an optical purity of 99% ee) were obtained.

【0016】実施例4 (R)−3−(2−ナフチル)−5−メトキシメチルオ
キサゾリジン−2−オンの製造:2−ナフチルイソシア
ネート25.6g(0.151 mol)をジメチルス
ルホキシド100mLに溶解し、フッ化セシウム2.2
9g(15.1 mmol)、(S)−4−メトキシメ
チル−1,3−ジオキソラン−2−オン20.0g
(0.151 mol、光学純度98%ee)を順次加
え、アルゴン気流下140℃で8時間撹拌する。不溶物
を瀘去し、瀘液を減圧下濃縮した後、残渣をシリカゲル
カラムクロマトグラフィーにより精製して標題の(R)
−3−(2−ナフチル)−5−メトキシメチルオキサゾ
リジン−2−オン34.0g(収率87.3%、光学純
度98%ee)を得た。
Example 4 Preparation of (R) -3- (2-naphthyl) -5-methoxymethyloxazolidine-2-one: 25.6 g (0.151 mol) of 2-naphthyl isocyanate was dissolved in 100 mL of dimethyl sulfoxide. , Cesium fluoride 2.2
9 g (15.1 mmol), (S) -4-methoxymethyl-1,3-dioxolan-2-one 20.0 g
(0.151 mol, 98% ee of optical purity) are sequentially added, and the mixture is stirred at 140 ° C. for 8 hours in an argon stream. After filtering off the insoluble matter and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R).
Thus, 34.0 g (yield: 87.3%, optical purity: 98% ee) of -3- (2-naphthyl) -5-methoxymethyloxazolidin-2-one was obtained.

【0017】実施例5 (R)−5−ベンジルオキシメチル−3−(4−シアノ
フェニル)オキサゾリジン−2−オンの製造:4−シア
ノフェニルイソシアネート13.8g(96.06 m
mol)をジメチルスルホキシド100mLに溶解し、
フッ化セシウム1.46g(9.606mmol)、
(S)−4−ベンジルオキシメチル−1,3−ジオキソ
ラン−2−オン20.0g(96.06 mmol、光
学純度98%ee)を順次加え、アルゴン気流下140
℃で8時間撹拌する。不溶物を瀘去し、瀘液を減圧下濃
縮した後、残渣をシリカゲルカラムクロマトグラフィー
により精製して標題の(R)−5−ベンジルオキシメチ
ル−3−(4−シアノフェニル)オキサゾリジン−2−
オン23.1g(収率78.0%、光学純度98%e
e)を得た。
Example 5 Preparation of (R) -5-benzyloxymethyl-3- (4-cyanophenyl) oxazolidine-2-one: 13.8 g (96.06 m) of 4-cyanophenylisocyanate
mol) in 100 mL of dimethyl sulfoxide,
1.46 g (9.606 mmol) of cesium fluoride,
20.0 g (96.06 mmol, optical purity 98% ee) of (S) -4-benzyloxymethyl-1,3-dioxolan-2-one were sequentially added, and the mixture was added under an argon stream at 140 ° C.
Stir at C for 8 hours. After filtering off the insolubles and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R) -5-benzyloxymethyl-3- (4-cyanophenyl) oxazolidin-2-
ON 23.1 g (yield 78.0%, optical purity 98% e
e) was obtained.

【0018】実施例6 (R)−3−(6−ベンジルオキシ−2−ナフチル)−
5−メトキシメチルオキサゾリジン−2−オンの製造:
6−ベンジルオキシ−2−ナフチルイソシアネート4
1.7g(0.151 mol)をジメチルスルホキシ
ド100mLに溶解し、フッ化セシウム2.29g(1
5.1 mmol)、(S)−4−メトキシメチル−
1,3−ジオキソラン−2−オン20.0g(0.15
1 mol、光学純度98%ee)を順次加え、アルゴ
ン気流下140℃で8時間撹拌する。不溶物を瀘去し、
瀘液を減圧下濃縮した後、残渣をシリカゲルカラムクロ
マトグラフィーにより精製して標題の(R)−3−(6
−ベンジルオキシ−2−ナフチル)−5−メトキシメチ
ルオキサゾリジン−2−オン45.2g(収率82.2
3%、光学純度98%ee)を得た。
Example 6 (R) -3- (6-benzyloxy-2-naphthyl)-
Preparation of 5-methoxymethyloxazolidin-2-one:
6-benzyloxy-2-naphthyl isocyanate 4
1.7 g (0.151 mol) was dissolved in 100 mL of dimethyl sulfoxide, and 2.29 g of cesium fluoride (1
5.1 mmol), (S) -4-methoxymethyl-
20.0 g of 1,3-dioxolan-2-one (0.15
1 mol and 98% ee) are sequentially added, and the mixture is stirred at 140 ° C. for 8 hours under a stream of argon. Filter off insolubles,
After the filtrate was concentrated under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R) -3- (6).
-Benzyloxy-2-naphthyl) -5-methoxymethyloxazolidin-2-one (45.2 g, yield 82.2)
3% and an optical purity of 98% ee) were obtained.

【0019】実施例7 (R)−5−ベンジルオキシメチル−3−(2−チエニ
ル)オキサゾリジン−2−オンの製造:2−チエニルイ
ソシアネート12.0g(96.06 mmol)をジ
メチルスルホキシド100mLに溶解し、フッ化セシウ
ム1.46g(9.606 mmol)、(S)−4−ベ
ンジルオキシメチル−1,3−ジオキソラン−2−オン
20.0g(96.06 mmol、光学純度98%e
e)を順次加え、アルゴン気流下140℃で9時間撹拌
する。不溶物を瀘去し、瀘液を減圧下濃縮した後、残渣
をシリカゲルカラムクロマトグラフィーにより精製して
標題の(R)−5−ベンジルオキシメチル−3−(2−
チエニル)オキサゾリジン−2−オン22.3g(収率
80.3%、光学純度98%ee)を得た。
Example 7 Preparation of (R) -5-benzyloxymethyl-3- (2-thienyl) oxazolidine-2-one: Dissolve 12.0 g (96.06 mmol) of 2-thienyl isocyanate in 100 mL of dimethyl sulfoxide. Then, 1.46 g (9.606 mmol) of cesium fluoride, 20.0 g (96.06 mmol, (S) -4-benzyloxymethyl-1,3-dioxolan-2-one, optical purity 98% e) of (S) -4-benzyloxymethyl-1,3-dioxolan-2-one
e) is added in sequence, and the mixture is stirred at 140 ° C. for 9 hours under a stream of argon. After filtering off the insoluble matter and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R) -5-benzyloxymethyl-3- (2-
22.3 g of (thienyl) oxazolidin-2-one (yield: 80.3%, optical purity: 98% ee) were obtained.

【0020】実施例8 (R)−3−(n−ブチル)−5−メトキシメチルオキ
サゾリジン−2−オンの製造:n−ブチルイソシアネー
ト11.3g(0.114 mol)をジメチルスルホ
キシド100mLに溶解し、フッ化セシウム1.72g
(11.4 mmol)、(S)−4−メトキシメチル
−1,3−ジオキソラン−2−オン15.0g(0.1
14 mol、光学純度98%ee)を順次加え、アル
ゴン気流下140℃で9時間撹拌する。不溶物を瀘去
し、瀘液を減圧下濃縮した後、残渣をシリカゲルカラム
クロマトグラフィーにより精製して標題の(R)−3−
(n−ブチル)−5−メトキシメチルオキサゾリジン−
2−オン18.7g(収率87.6%、光学純度98%
ee)を得た。
Example 8 Preparation of (R) -3- (n-butyl) -5-methoxymethyloxazolidine-2-one: 11.3 g (0.114 mol) of n-butyl isocyanate was dissolved in 100 mL of dimethyl sulfoxide. 1.72 g of cesium fluoride
(11.4 mmol), 15.0 g of (S) -4-methoxymethyl-1,3-dioxolan-2-one (0.1
14 mol and 98% ee of optical purity are sequentially added, and the mixture is stirred at 140 ° C. for 9 hours under an argon stream. After filtering off the insolubles and concentrating the filtrate under reduced pressure, the residue was purified by silica gel column chromatography to give the title (R) -3-
(N-butyl) -5-methoxymethyloxazolidine-
18.7 g of 2-one (87.6% yield, 98% optical purity)
ee) was obtained.

【0021】[0021]

【発明の効果】本発明方法によれば、目的とするオキサ
ゾリジン−2−オン類(3)あるいはその光学活性体を
収率よく、そしてその光学活性体の場合には、光学純度
を損なうことなく製造することができる。
According to the method of the present invention, the desired oxazolidine-2-ones (3) or their optically active substances are obtained in good yield, and in the case of the optically active substances, the optical purity is not impaired. Can be manufactured.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 下記式(1) 【化1】 (式中R1、R2、R3およびR4は、水素原子、直鎖, 分
岐もしくは環状のアルキル基、アルコキシ基, 置換アミ
ノ基あるいはアルキルチオ基を有する直鎖もしくは分岐
のアルキル基、置換もしくは無置換のアラルキル基、ま
たは置換もしくは無置換のアリール基を意味する。)で
表される1,3−ジオキソラン−2−オン類と下記式
(2) 【化2】 (式中R5は、水素原子、直鎖, 分岐もしくは環状のア
ルキル基、置換もしくは無置換のアラルキル基、ハロゲ
ノスルホニル基、トリアルキルシリル基、置換もしくは
無置換のアリールスルホニル基、または置換もしくは無
置換の芳香族基を意味する。)で表されるイソシアネー
ト類とを、フッ素塩存在下反応させることを特徴とする
下記式(3) 【化3】 (式中R1、R2、R3、R4およびR5は、前掲と同じ基
を意味する。)で表されるオキサゾリジン−2−オン類
の製造方法。
[Claim 1] The following formula (1) (Wherein R 1 , R 2 , R 3 and R 4 are a hydrogen atom, a linear or branched alkyl group having a linear or branched or cyclic alkyl group, an alkoxy group, a substituted amino group or an alkylthio group, a substituted or 1,3-dioxolan-2-one represented by an unsubstituted aralkyl group or a substituted or unsubstituted aryl group) and the following formula (2): (In the formula, R 5 is a hydrogen atom, a linear, branched or cyclic alkyl group, a substituted or unsubstituted aralkyl group, a halogenosulfonyl group, a trialkylsilyl group, a substituted or unsubstituted arylsulfonyl group, or a substituted or unsubstituted group. Is substituted with an isocyanate represented by the following formula (3): (Wherein R 1 , R 2 , R 3 , R 4 and R 5 represent the same groups as described above).
【請求項2】 下記式(1a) 【化4】 (式中R11、R21、R31およびR41は、水素原子、C1
〜C4の低級アルキル基、メトキシメチル基、ベンジル
オキシメチル基またはベンジル基を意味する。)で表さ
れる1,3−ジオキソラン−2−オン類と下記式(2
a) 【化5】 (式中R51は、水素原子、C1〜C4の低級アルキル基、
ベンジル基、フェニル基、シアノフェニル基、ナフチル
基またはチエニル基を意味する。)で表されるイソシア
ネート類とを、フッ素塩存在下反応させることを特徴と
する下記式(3a) 【化6】 (式中R11、R21、R31、R41およびR51は、前掲と同
じ基を意味する。)で表されるオキサゾリジン−2−オ
ン類の製造方法。
2. The following formula (1a): (Wherein R 11 , R 21 , R 31 and R 41 represent a hydrogen atom, C 1
-C 4 lower alkyl group, a methoxymethyl group, means a benzyloxymethyl group or a benzyl group. ) And 1,3-dioxolan-2-ones represented by the following formula (2)
a) embedded image (Wherein R 51 is a hydrogen atom, a C 1 -C 4 lower alkyl group,
It means a benzyl group, a phenyl group, a cyanophenyl group, a naphthyl group or a thienyl group. ) Is reacted with a isocyanate represented by the following formula (3a): (Wherein R 11 , R 21 , R 31 , R 41 and R 51 mean the same groups as described above).
【請求項3】 フッ素塩がフッ素のアルカリ金属塩また
はアルカリ土類金属塩である請求項1または2記載のオ
キサゾリジン−2−オン類の製造方法。
3. The method for producing oxazolidin-2-ones according to claim 1, wherein the fluorine salt is an alkali metal salt or an alkaline earth metal salt of fluorine.
【請求項4】 フッ素塩がフッ化セシウムまたはフッ化
カリウムである請求項1〜3記載のオキサゾリジン−2
−オン類の製造方法。
4. The oxazolidine-2 according to claim 1, wherein the fluorine salt is cesium fluoride or potassium fluoride.
-A method for producing ons.
【請求項5】 反応溶媒がN,N−ジメチルホルムアミ
ドまたはジメチルスルホキシドである請求項1〜4記載
のオキサゾリジン−2−オン類の製造方法。
5. The process according to claim 1, wherein the reaction solvent is N, N-dimethylformamide or dimethylsulfoxide.
【請求項6】 光学活性な1,3−ジオキソラン−2−
オン類を用い、光学活性なオキサゾリジン−2−オン類
を製造する請求項1〜5のいずれかに記載のオキサゾリ
ジン−2−オン類の製造方法。
6. An optically active 1,3-dioxolan-2-amine.
The method for producing an oxazolidin-2-one according to any one of claims 1 to 5, wherein the optically active oxazolidine-2-one is produced using the one.
JP9752999A 1999-04-05 1999-04-05 Process for producing oxazolidin-2-ones Expired - Fee Related JP3740886B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9752999A JP3740886B2 (en) 1999-04-05 1999-04-05 Process for producing oxazolidin-2-ones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9752999A JP3740886B2 (en) 1999-04-05 1999-04-05 Process for producing oxazolidin-2-ones

Publications (2)

Publication Number Publication Date
JP2000290265A true JP2000290265A (en) 2000-10-17
JP3740886B2 JP3740886B2 (en) 2006-02-01

Family

ID=14194791

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9752999A Expired - Fee Related JP3740886B2 (en) 1999-04-05 1999-04-05 Process for producing oxazolidin-2-ones

Country Status (1)

Country Link
JP (1) JP3740886B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074785B2 (en) 2001-09-17 2006-07-11 Bayer Cropscience Ag Δ1-pyrrolines used as pesticides
WO2008120655A1 (en) * 2007-03-30 2008-10-09 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i
CN104370939A (en) * 2014-10-14 2015-02-25 上海交通大学 Preparation method of chiral dihydropyrrole compound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074785B2 (en) 2001-09-17 2006-07-11 Bayer Cropscience Ag Δ1-pyrrolines used as pesticides
WO2008120655A1 (en) * 2007-03-30 2008-10-09 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i
JPWO2008120655A1 (en) * 2007-03-30 2010-07-15 株式会社医薬分子設計研究所 Oxazolidinone derivatives having type I 11β-hydroxysteroid dehydrogenase inhibitory activity
US7998992B2 (en) 2007-03-30 2011-08-16 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1
CN104370939A (en) * 2014-10-14 2015-02-25 上海交通大学 Preparation method of chiral dihydropyrrole compound

Also Published As

Publication number Publication date
JP3740886B2 (en) 2006-02-01

Similar Documents

Publication Publication Date Title
WO2007012954A1 (en) An improved process for the preparation of escitalopram
JP3334595B2 (en) Process for producing oxazolidine-2-one derivative
JP3675274B2 (en) Method for producing 9- (2-hydroxyalkyl) purine derivative and 1- (2-hydroxyalkyl) pyrimidine derivative
JP3740886B2 (en) Process for producing oxazolidin-2-ones
CN1229077A (en) Process for preparation of 3-amino-pyrrolidine derivatives
JPS61227533A (en) Reversion of secondary alcohol configuration
CN108610306B (en) Synthetic method of 2H-1, 4-thiazine-3 (4H) -ketone derivative
WO1998012171A1 (en) Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
JP2003206282A (en) Method for producing oxazolidin-2-one derivative
CN113429409A (en) Sulfur-containing polysubstituted indolizine compound and preparation method thereof
KR100514819B1 (en) Process for producing chiral glycidyl derivatives
CN1210856A (en) Process for preparation of heteroarylcarboxamides
RU2204552C2 (en) Method of synthesis of (r)-(+)-2-[4-(5-chloro-3-fluoro- -pyridine-2-yloxy)phenoxy]-propionic acid ester
CN109879832B (en) 4-alkoxy-2-aryl mercaptomorpholine-3, 5-dione compound and preparation method thereof
JPH07165743A (en) Production of optically active glycidyl tosylate
CN1092763A (en) Preparation of beta-methylcarbapenem intermediates
NZ210718A (en) The preparation of azetidinones
JP2000198774A (en) Optically active guanidine derivative
JPH04225947A (en) Process for producing chiral epoxides and intermediates
KR101117512B1 (en) Method for production of 4,10ß-diacetoxy-2a-benzoyloxy-5ß,20-epoxy-1,13a-dihydroxy-9-oxo-19-norcyclopropa[g]tax-11-ene
CN117603107A (en) Perfluoro hydrocarbon thio silver reagent and preparation and application method thereof
JP4614026B2 (en) Process for producing N-substituted-5-hydroxy-tetrahydro-2-pyrimidinone
KR101881918B1 (en) New process for the synthesis of acylsulfonamides derivatives
JP2000198775A (en) Cyclic guanidine and its production
JP2580282B2 (en) Method for producing polyoxacyclodiene compound

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050705

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050817

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20051018

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20051031

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081118

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091118

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091118

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101118

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111118

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121118

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131118

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141118

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees